🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Tapentadol is FDA approved for the treatment of moderate to severe acute pa...
Status
Completed
Location
Mayo Clinic in Rochester
Start Date
2011-05
Trial ID
NCT01500317
Treatments Being Tested
Evaluate how NUCYNTA (tapentadol) immediate release (IR) compares with oxyc...
Status
Completed
Location
Multiple Locations
Start Date
2009-09
Trial ID
NCT00986180
Treatments Being Tested
The purpose of this study is to test in patients who have had hip replaceme...
Status
Terminated
Location
Multiple Locations
Start Date
2006-10
Trial ID
NCT00364533
Treatments Being Tested
The purpose of this study is to demonstrate the efficacy of at least 1 dose...
Status
Completed
Location
Multiple Locations
Start Date
2012-01
Trial ID
NCT01516008
Treatments Being Tested
The main objective of this study is to demonstrate the efficacy and safety ...
Status
Completed
Location
Site 13
Start Date
2007-05
Trial ID
NCT00478023
The purpose of this study is to determine the effectiveness and safety of t...
Status
Completed
Location
Multiple Locations
Start Date
2008-09
Trial ID
NCT00771758
Treatments Being Tested
The purpose of this study is to evaluate the analgesic efficacy and safety ...
Status
Completed
Location
Multiple Locations
Start Date
2013-01
Trial ID
NCT01813890
Treatments Being Tested